Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Blood Pressure Determination | 7 | 2018 | 450 | 2.09 | Why? |
| Contrast Media | 4 | 2019 | 1011 | 1.85 | Why? |
| Nephrology | 4 | 2020 | 546 | 1.62 | Why? |
| Gadolinium | 2 | 2019 | 318 | 1.36 | Why? |
| Image Enhancement | 2 | 2019 | 177 | 1.32 | Why? |
| Kidney Diseases | 4 | 2020 | 1434 | 1.14 | Why? |
| Acute Kidney Injury | 9 | 2020 | 5762 | 1.05 | Why? |
| Hypertension | 9 | 2020 | 8895 | 0.88 | Why? |
| Adrenergic alpha-Antagonists | 1 | 2019 | 9 | 0.82 | Why? |
| Peer Review, Research | 2 | 2020 | 407 | 0.77 | Why? |
| Triiodobenzoic Acids | 1 | 2018 | 12 | 0.75 | Why? |
| Renal Replacement Therapy | 5 | 2020 | 1530 | 0.74 | Why? |
| Sphygmomanometers | 1 | 2017 | 14 | 0.71 | Why? |
| Renal Insufficiency, Chronic | 6 | 2018 | 2654 | 0.70 | Why? |
| Fibromuscular Dysplasia | 1 | 2017 | 9 | 0.70 | Why? |
| Blood Pressure Monitors | 1 | 2017 | 28 | 0.69 | Why? |
| Hypertension, Renovascular | 1 | 2017 | 14 | 0.69 | Why? |
| Blood Pressure | 7 | 2018 | 2198 | 0.65 | Why? |
| Catheters, Indwelling | 1 | 2017 | 84 | 0.63 | Why? |
| Hemodynamics | 3 | 2019 | 1562 | 0.62 | Why? |
| Hypotension | 1 | 2019 | 392 | 0.60 | Why? |
| Device Removal | 1 | 2017 | 221 | 0.56 | Why? |
| Peer Review | 1 | 2017 | 204 | 0.56 | Why? |
| Observation | 1 | 2013 | 80 | 0.52 | Why? |
| Sympathectomy | 1 | 2013 | 67 | 0.50 | Why? |
| Heart Valve Prosthesis | 1 | 2018 | 533 | 0.48 | Why? |
| Renal Dialysis | 6 | 2018 | 4358 | 0.46 | Why? |
| Withholding Treatment | 1 | 2018 | 798 | 0.45 | Why? |
| Kidney | 5 | 2019 | 3648 | 0.45 | Why? |
| Cardiac Catheterization | 1 | 2018 | 882 | 0.42 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.42 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.41 | Why? |
| Education, Medical, Continuing | 1 | 2017 | 638 | 0.40 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.39 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2018 | 839 | 0.38 | Why? |
| Pain | 1 | 2017 | 1084 | 0.38 | Why? |
| Blood Pressure Monitoring, Ambulatory | 3 | 2018 | 341 | 0.37 | Why? |
| Periodicals as Topic | 3 | 2020 | 1492 | 0.37 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.34 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 5277 | 0.34 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.33 | Why? |
| Canada | 6 | 2019 | 6018 | 0.33 | Why? |
| Diuretics | 2 | 2018 | 326 | 0.30 | Why? |
| Patient Care Management | 1 | 2017 | 1514 | 0.29 | Why? |
| Medication Adherence | 1 | 2013 | 1270 | 0.26 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 1454 | 0.26 | Why? |
| Liver Transplantation | 1 | 2019 | 2864 | 0.25 | Why? |
| Internet | 2 | 2020 | 6204 | 0.24 | Why? |
| Education, Medical, Graduate | 1 | 2017 | 2082 | 0.24 | Why? |
| Antihypertensive Agents | 4 | 2019 | 1962 | 0.24 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.24 | Why? |
| Radiologists | 2 | 2019 | 873 | 0.24 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.23 | Why? |
| Peritoneal Dialysis | 2 | 2017 | 498 | 0.22 | Why? |
| Kidney Failure, Chronic | 4 | 2018 | 3222 | 0.21 | Why? |
| Blogging | 1 | 2020 | 44 | 0.21 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.19 | Why? |
| Social Media | 2 | 2020 | 5798 | 0.19 | Why? |
| Open Access Publishing | 1 | 2020 | 116 | 0.19 | Why? |
| Piperacillin | 1 | 2018 | 63 | 0.18 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.18 | Why? |
| Incidence | 6 | 2019 | 25622 | 0.17 | Why? |
| Hyperphosphatemia | 1 | 2017 | 20 | 0.17 | Why? |
| Oscillometry | 1 | 2017 | 50 | 0.17 | Why? |
| Albuminuria | 1 | 2018 | 164 | 0.17 | Why? |
| Humans | 42 | 2020 | 930598 | 0.16 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.16 | Why? |
| Hemoperfusion | 1 | 2020 | 260 | 0.16 | Why? |
| Spironolactone | 1 | 2017 | 114 | 0.16 | Why? |
| Syncope | 1 | 2019 | 238 | 0.16 | Why? |
| Arteriovenous Shunt, Surgical | 1 | 2016 | 93 | 0.15 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2018 | 155 | 0.15 | Why? |
| Women, Working | 1 | 2017 | 96 | 0.15 | Why? |
| Dilatation | 1 | 2017 | 181 | 0.15 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.15 | Why? |
| Access to Information | 1 | 2020 | 483 | 0.15 | Why? |
| Equipment Failure | 1 | 2017 | 197 | 0.15 | Why? |
| Hypokalemia | 1 | 2017 | 195 | 0.15 | Why? |
| Editorial Policies | 1 | 2020 | 408 | 0.14 | Why? |
| Creatinine | 2 | 2018 | 1443 | 0.14 | Why? |
| History, 19th Century | 1 | 2017 | 384 | 0.14 | Why? |
| Accidental Falls | 1 | 2019 | 448 | 0.14 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.13 | Why? |
| Occupational Health Services | 1 | 2017 | 219 | 0.13 | Why? |
| Fractures, Bone | 1 | 2019 | 487 | 0.13 | Why? |
| Curcumin | 1 | 2018 | 396 | 0.12 | Why? |
| Dose-Response Relationship, Drug | 2 | 2019 | 3776 | 0.12 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.12 | Why? |
| Societies, Medical | 2 | 2019 | 6907 | 0.12 | Why? |
| Preventive Health Services | 1 | 2018 | 501 | 0.12 | Why? |
| Proportional Hazards Models | 3 | 2019 | 6543 | 0.11 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.11 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.11 | Why? |
| Women's Health | 1 | 2017 | 444 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Drug Resistance | 1 | 2013 | 395 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Propensity Score | 1 | 2019 | 2690 | 0.11 | Why? |
| Geriatric Assessment | 1 | 2019 | 1372 | 0.10 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.09 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
| Cardiovascular Diseases | 3 | 2018 | 11497 | 0.09 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.08 | Why? |
| Risk Assessment | 7 | 2020 | 25439 | 0.08 | Why? |
| Kidney Function Tests | 2 | 2020 | 520 | 0.08 | Why? |
| Critical Illness | 4 | 2018 | 17281 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.08 | Why? |
| Female | 18 | 2020 | 380317 | 0.07 | Why? |
| Sleep Apnea, Obstructive | 1 | 2013 | 668 | 0.07 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.07 | Why? |
| Treatment Outcome | 4 | 2019 | 51732 | 0.07 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.07 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.07 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.07 | Why? |
| Chi-Square Distribution | 2 | 2017 | 961 | 0.07 | Why? |
| Disease Progression | 3 | 2017 | 13580 | 0.07 | Why? |
| Aged | 13 | 2019 | 215776 | 0.06 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.06 | Why? |
| Middle Aged | 13 | 2018 | 270681 | 0.06 | Why? |
| Obesity, Morbid | 1 | 2013 | 1340 | 0.06 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Male | 15 | 2020 | 367725 | 0.05 | Why? |
| Occupational Health | 1 | 2017 | 3965 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Natriuretic Peptide, C-Type | 1 | 2018 | 4 | 0.05 | Why? |
| Retrospective Studies | 7 | 2019 | 105322 | 0.05 | Why? |
| Drug Therapy, Combination | 1 | 2013 | 7268 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2019 | 88759 | 0.05 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.05 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.04 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.04 | Why? |
| Dialysis Solutions | 1 | 2018 | 76 | 0.04 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Calcium Carbonate | 1 | 2017 | 10 | 0.04 | Why? |
| Dimensional Measurement Accuracy | 1 | 2017 | 56 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2017 | 98 | 0.04 | Why? |
| Phosphates | 1 | 2017 | 135 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Interleukin-18 | 1 | 2018 | 328 | 0.04 | Why? |
| Comparative Effectiveness Research | 1 | 2017 | 178 | 0.04 | Why? |
| Intensive Care Units | 3 | 2018 | 29594 | 0.04 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.04 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.03 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.03 | Why? |
| Monte Carlo Method | 1 | 2017 | 577 | 0.03 | Why? |
| Stroke | 1 | 2017 | 8839 | 0.03 | Why? |
| Medication Therapy Management | 1 | 2017 | 312 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Cause of Death | 2 | 2017 | 4823 | 0.03 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2018 | 693 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Ontario | 1 | 2017 | 1966 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Self Care | 1 | 2017 | 918 | 0.02 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.02 | Why? |
| Adult | 7 | 2018 | 244371 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.02 | Why? |
| Health Promotion | 1 | 2018 | 2020 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Hiremath's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(76)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_